| Leon Sergio Duplan Fraustro |
Leon Sergio Duplan Fraustro is currently the Chairman at Aerie Pharmaceuticals, Inc. He is also a Director at Alcon Foundation, Inc., Alcon Canada, Inc., and Helen Keller International. In 2012, he became the President-North America Division at Alcon AG. Prior to his current positions, he served as the Head & Country President-Novartis Mexico at Novartis de Mexico SA de CV from 2008 to 2012. Mr. Duplan Fraustro completed his undergraduate degree at Universidad Iberoamericana and holds an MBA from The Wharton School of the University of Pennsylvania. |
| Gianluca Corbinelli |
Gianluca Corbinelli currently works for Aerie Pharmaceuticals, Inc. as the Chief Commercial Officer-European Union. |
| Andrew Allen |
Andrew Allen currently works at Aerie Pharmaceuticals, Inc., as Chief Compliance Officer. |
| Timothy C. Stonesifer |
Timothy C. Stonesifer is currently the Director at Insulet Corp., the Chief Financial Officer at Alcon AG, and the Treasurer at Aerie Pharmaceuticals, Inc. He previously held positions as Treasurer, Director & Vice President at Nimble Storage, Inc., Secretary & Director at DXC Technology Co., Chief Financial Officer-Plastics Business at GE Aerospace, Chief Financial Officer at GE Plastics, Chief Financial Officer-International Operations at General Motors China LLC, Chief Financial Officer & Executive Vice President at Hewlett Packard Enterprise Co., Chief Financial Officer at Algeco Scotsman, and Chief Financial Officer & Senior Vice President at HP Development Co. LP. Mr. Stonesifer obtained his undergraduate degree from the University of Michigan. |
| Gary Jay Sternberg |
Gary Jay Sternberg is the founder of Stargazer Pharmaceuticals, Inc. He currently holds the position of Chief Executive Officer at RainBio, Inc. since 2021 and Chief Medical Officer at Aerie Pharmaceuticals, Inc. since 2022. Previously, he served as Chief Executive Officer at Tisbury Pharmaceuticals, Inc. and held the position of Director-Sales at Fovea Pharmaceuticals SA from 2006 to 2009. He also worked as Group Medical Director & Head-Medical Affairs at GeneTech, Inc. Additionally, he served as Chief Business Officer at Sesen Bio, Inc. from 2014 to 2016. Dr. Sternberg obtained an MBA from The University of Chicago and a doctorate from The State University of New York. |
| Michelle Senchyna |
Michelle Senchyna is currently the VP-Clinical Development & Medical Affairs at Aerie Pharmaceuticals, Inc. She previously worked as the Executive Director-Ophthalmology at Allergan, Inc. and as the Director-Clinical Development at PanOptica, Inc. Prior to her industry experience, she was an Assistant Professor at The University of Waterloo. Dr. Senchyna received her undergraduate and doctorate degrees from McMaster University. |
| David J. Endicott |
David J. Endicott is currently the Chief Executive Officer & Director at Alcon AG, the President & Chief Executive Officer at Aerie Pharmaceuticals, Inc., the Chief Executive Officer at Transcend Medical, Inc., the President & Chief Executive Officer at TrueVision Systems, Inc., the Chief Executive Officer at Alcon NV, the Chief Executive Officer & Director at Alcon Vision LLC, the Chief Executive Officer at PowerVision, Inc., and a Director at the Advanced Medical Technology Association. He previously served as the Chief Executive Officer at Ciba Vision Corp., a Director at Orexigen Therapeutics, Inc., an Independent Director at ZELTIQ Aesthetics, Inc., and the Vice President at Allergan, Inc. He also held positions at Hospira, Inc., Allergan Ltd., and Pfizer Inc. Mr. Endicott holds an MBA from the University of Southern California and an undergraduate degree from Whitman College. |
